LivingGLP1
Study S000070

The Effect of Parenterally Administred Semaglutide on Intestinal Iron Absorption in Individuals With Type 2 Diabetes Mellitus

ClinicalTrials.gov record

Registration

Registration
NCT06629688
Study type
INTERVENTIONAL
Masking
NONE
Status
COMPLETED
Enrollment
51
Start
2023-11-01
Primary completion
2024-04-01
Lead sponsor
University Hospital Dubrava
Conditions
Diabetes Mellitus Type 2; Iron Absorption
Interventions
DRUG:semaglutide
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • General objective [10 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.